United Kingdom government approves Astra-Oxford coronavirus vaccine


"While decisions on alternative dosing regimens reside with health authorities, Pfizer believes it is critical.to ensure each recipient is afforded the maximum possible protection, which means immunisation with two doses of the vaccine".

45, a nurse at two different local hospitals, said in a Facebook post on December 18 that he had received the Pfizer vaccine, telling the ABC News affiliate that his arm was sore for a day but that he had suffered no other side-effects. It's the second coronavirus injection to be cleared for emergency use in United Kingdom after Pfizer Inc. and BioNTech SE's in early December.

The UK has ordered 100 million doses from the manufacturer AstraZeneca - enough to vaccinate 50 million people.

A USA nurse has tested positive for COVID-19 eight days after having received a Pfizer vaccine shot.

"But...we must act to suppress the virus now, especially as the new variant makes the time between now and then even more hard". Ruud Dobber, president of AZ's US business, told CNBC he expected regulators to focus on the half-dose regimen, hypothesizing the smaller initial dose may have worked by "priming the immune system with a relatively low dose or lower dose". In the meantime, the drugmaker is also pursuing an emergency use listing from the World Health Organization-a bid to speed up vaccine access in low- and middle-income countries. The company added it has no data to show that protection from one dose lasts longer than 21 days.

South Africa tops 1 million coronavirus cases
Africa's worst-hit country previously banned alcohol sales in March when it was battling its first wave of infections. He also chaired a virtual meeting of the President's Coordinating Council (PCC) and met with Cabinet on Monday.

Oxford University's Dr. Andrew Pollard, one of the leaders of the vaccine development team, offered hope the newly authorized shot will help.

The Oxford vaccine, being made in Oxfordshire and Staffordshire, can be stored in a standard fridge, unlike the Pfizer/BioNTech jab, which needs cold storage of around -70C.

Over a dozen countries have already approved the vaccine for use, including Britain, Canada, Mexico, Saudi Arabia and Bahrain. Meanwhile, the company is continuing to work with global partners to build out manufacturing capacity for up to 3 billion doses globally in 2021 on a rolling basis, it says.

"Employers in the care sector must ensure there's paid time for staff getting the jab so they're not left out of pocket for doing the right thing to protect vulnerable people".

The AstraZeneca vaccine, like the Pfizer option, requires two doses to be given to patients. The country is reportedly preparing to inoculate a million people per week with the homegrown vaccine at pop-up sites in soccer stadiums and race tracks.